Trademark: 90072526
Status Date
Monday, October 18, 2021
Filing Date
Friday, July 24, 2020
Published for Opposition
Tuesday, January 19, 2021
Abandoned Date
Monday, October 18, 2021
5 pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Immunoglobulin A Nephropathy (IgAN); pharmaceutical preparations for the treatment of Alport Syndrome
Oct 18, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 18, 2021
Abandonment - No Use Statement Filed
Mar 16, 2021
Noa E-Mailed - Sou Required From Applicant
Jan 19, 2021
Official Gazette Publication Confirmation E-Mailed
Jan 19, 2021
Published For Opposition
Dec 30, 2020
Notification Of Notice Of Publication E-Mailed
Dec 23, 2020
Automatic Update Of Assignment Of Ownership
Dec 14, 2020
Assigned To Lie
Dec 14, 2020
Approved For Pub - Principal Register
Dec 12, 2020
Teas/Email Correspondence Entered
Dec 11, 2020
Correspondence Received In Law Office
Dec 11, 2020
Teas Response To Office Action Received
Nov 16, 2020
Notification Of Priority Action E-Mailed
Nov 16, 2020
Priority Action E-Mailed
Nov 16, 2020
Priority Action Written
Nov 10, 2020
Assigned To Examiner
Aug 24, 2020
New Application Office Supplied Data Entered In Tram
Jul 28, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
